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Abstract
Seizure-triggeredmaladaptive neural plasticity and neuroinflammation occur during the latent period as a key underlying event in
epilepsy chronicization. Previously, we showed that α-tocopherol (α-T) reduces hippocampal neuroglial activation and neuro-
degeneration in the rat model of kainic acid (KA)-induced status epilepticus (SE). These findings allowed us to postulate an
antiepileptogenic potential for α-T in hippocampal excitotoxicity, in line with clinical evidence showing that α-T improves
seizure control in drug-resistant patients. To explore neurobiological correlates of the α-T antiepileptogenic role, rats were
injected with such vitamin during the latent period starting right after KA-induced SE, and the effects on circuitry excitability,
neuroinflammation, neuronal death, and microRNA (miRNA) expression were investigated in the hippocampus. Results show
that in α-T-treated epileptic rats, (1) the number of population spikes elicited by pyramidal neurons, as well as the latency to the
onset of epileptiform-like network activity recover to control levels; (2) neuronal death is almost prevented; (3) down-regulation
of claudin, a blood–brain barrier protein, is fully reversed; (4) neuroinflammation processes are quenched (as indicated by the
decrease of TNF-α, IL-1β, GFAP, IBA-1, and increase of IL-6); (5) miR-146a, miR-124, and miR-126 expression is coherently
modulated in hippocampus and serum by α-T. These findings support the potential of a timely intervention with α-T in clinical
management of SE to reduce epileptogenesis, thus preventing chronic epilepsy development. In addition, we suggest that the
analysis of miRNA levels in serum could provide clinicians with a tool to evaluate disease evolution and the efficacy of α-T
therapy in SE.
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Introduction
Seizures are common neurological symptoms that may require
treatment, but not all seizures evolve into epilepsy. The asser-
tion Bseizures beget seizures^ involves a role of epileptic activ-
ity in initiating the epileptogenic process but also in maintain-
ing it, moving toward a chronicity of epilepsy [1]. Between the
initial event and the onset of chronic epilepsy, there is a gap of
variable duration, currently referred to as latent period, during
which several changes occur in brain structures that are associ-
ated with the alteration of network excitability and synchroni-
zation and may account for epileptogenesis [1, 2]. Indeed, an
initial epileptogenic insult can cause cell loss followed by syn-
aptic reorganization of surviving neuronal elements, axonal
sprouting within excitatory pathways amplified by loss of in-
hibitory interneurons, and anomalous neurogenesis [3]; all
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these rearrangements may induce the emergence of aberrant
excitatory and inhibitory connections, leading to epileptiform
hypersynchronization. In addition, gliosis, glial alterations, cy-
tokine production, such as IL-1β and TNF-α, and thus neuro-
inflammation can alter neuronal excitability and synchronicity,
by modulating receptor function and expression, contributing
to the chronicity of epilepsy [4–7]. These changes, which may
be referred to as maladaptive plasticity [8], have been found in
animal models of epilepsy that mimic the typical sequence of
initial event–latent period–chronic epilepsy, but also in tempo-
ral lobe tissue samples from patients who underwent surgery
for drug-resistant mesial temporal lobe epilepsy (MTLE) [9]. In
recent years, numerous antiepileptic drugs (AEDs) have been
developed, but several unmet clinical needs still remain, includ-
ing resistance to AEDs found in about 30% of patients, adverse
effects elicited by AEDs that can further reduce quality of life,
and the lack of treatments that can prevent development of
epilepsy in patients at risk, by reducing seizure-triggered mal-
adaptive neural plasticity underlying epileptogenic processes.
Since a wealth of studies have underscored a rise in oxida-
tive stress in epilepsy, thus asserting that free radicals can act
as a pathogen in the disease [10, 11], natural compounds with
antioxidant properties were considered in preventing seizure-
induced pathology [12, 13]. Among these, vitamin E was
proved to have beneficial effects in epilepsy, i.e., attenuating
convulsive behavior and brain oxidative stress [14, 15].
Indeed, as shown in diverse experimental models, pretreat-
ment with vitamin E reduces seizure-induced oxygen and ni-
trogen free radicals generation on a time scale of minutes to
hours [15–18], thereby decreasing the severity of seizures and
their detrimental effects. In addition, patients showing resis-
tance to AEDs have benefited from vitamin E treatment, im-
proving seizure control [19, 20]. In all these studies, the anti-
oxidant role of vitamin E was assumed to be accountable for
its effects on epileptic disease. However, as described above,
neuroinflammation is also involved in the pathophysiology of
epilepsy, contributing to epileptogenesis [21, 22] and vitamin
E, mainly α-tocopherol (α-T, the isoform showing the highest
in vivo biological activity and bioavailability), has numerous
compelling non-antioxidant actions [23], suggesting a possi-
ble antioxidant independent mechanism involved inmediating
its effects on epilepsy. Furthermore, a role of vitamin E has
also been demonstrated in regulating cell signaling through
microRNA (miRNA) modulation [24]. MiRNAs are small
non-coding RNAs able to regulate gene expression targeting
many mRNAs. In this way, miRNAs can also regulate tran-
scription factor expression, modulating in turn all cellular
pathways, including inflammatory cascades. Some miRNAs
involved in the modulation of inflammatory process, i.e.,
miR-146a and miR-124, were recently identified as epigenetic
modulators of seizure and epilepsy in animal models. The
brain delivery of a synthetic mimic of miR-146a, the master
modulator of the TLR4/NF-kB pro-inflammatory intracellular
signaling, was able to reduce the network excitability in the
hippocampus of a mouse model of epileptogenesis [25]. MiR-
124 was investigated as a candidate dual regulator of Neuron
Restrictive Silencer Factors (NRSF) and inflammatory path-
ways, showing that it is aberrantly expressed during
epileptogenesis [26]. In addition, miR-126, one of the most
highly expressed miRs in endothelial cells, plays a crucial role
in blood–brain barrier integrity [27], which is impaired during
epileptogenesis [28].
Recently, we demonstrated that post-seizure administration
of α-T for 4 days [29] quenches the neuroinflammatory and
neurodegenerative processes of kainic acid-induced status ep-
ilepticus (SE), by reducing neuron degeneration and spine loss
and decreasing astrocytosis and microglia activation. These
findings could be consistent with the hypothesis that α-T
antiepileptogenic potential may be ascribed to additional
mechanisms beyond the antioxidant one. Here, we extended
the α-T treatment throughout the latent period to further in-
vestigate the antiepileptogenic potential of α-T and the mech-
anisms involved. Thus, we used an acute administration of
kainic acid as chemoconvulsant agent, which induces a state
of prolonged SE, followed by spontaneous recurrent seizures
beginning after a latency of about 15 days [30–32]. Therefore,
we decided to investigate the excitability of hippocampus cir-
cuitry in adult rat with and without α-T post-ictal treatment at
this time point (15 days after SE). To address this issue, we
performed electrophysiological field recordings in CA1 of
brain slices from kainate-treated rats, to assess population
spikes, as an index of susceptibility to develop further spon-
taneous seizures [33]. Brain slices were then challenged with
GABAA-receptor antagonist bicuculline and the potassium
channel blocker 4-aminopyridine to induce epileptiform activ-
ity to evaluate seizure threshold. In addition, influence of α-T
treatment on GABA and AMPA currents were also investigat-
ed in Xenopus oocytes microinjected with hippocampal mem-
branes from adult rat with and without α-T post-ictal
treatment.
Neuroinflammation markers, oxidative stress, and neurode-
generation were assessed in hippocampi from the different ex-
perimental groups. Finally, we tested the potential relevance of
selected circulating miRNAs as epileptogenesis biomarkers.
Materials and Methods
Animals
Adult male Sprague-Dawley albino rats (Charles River, Italy)
were used in accordance with the Italian law on animal exper-
imentation (D.lgs 26/2014; research project permitted with
authorization N. 465/2015-PR by Italian Ministry of Health).
Rats (n = 72) were administered an acute intraperitoneal
(i.p.) injection of kainic acid (KA, 10 mg/kg b.w. in
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physiological saline) and seizure behavior was observed and
scored according to the Racine scale, up to the manifestation
of a full SE [34]. Briefly, typical wet dog shakes, full limbic
motor seizures, including rearing and loss of postural control,
sequentially appeared, and approximately 3 h after KA injec-
tion, animals showed profuse salivation, circling and jumping,
and SE. Three hours after the appearance of SE, crises were
interrupted by diazepam (2 mg/kg b.w.). Animals showing all
the Racine scale steps up to the overt status epilepticus were
considered (n = 48); about 20% of the kainate-injected rats
died during or early after the SE, while approximately 14%
did not clearly show the full progression of Racine stages.
Epileptic rats were randomly divided in two groups: (1) ani-
mals to be treated with an i.p. bolus ofα-Tonce a day up to the
15th day (n = 24; αK) (250 mg/kg b.w. for the first 4 days
followed by 2 mg/kg for the remaining days), (2) rats (n =
24; VK) injected with vehicle. In addition, other animals (n =
42) were injected with physiological saline instead of kainic
acid (non-epileptic rats): half of them (n = 21; αC) were treat-
ed with α-T (once a day, for 15 days following the same
schedule described above) and the other half (n = 21; VC)
with vehicle. Epileptic rats were monitored, using the Racine
scale steps, for spontaneous seizure arising up to the conclu-
sion of treatment protocols. Rats belonging to all the groups
were anesthetized and sacrificed as described below.
Electrophysiological Analyses
Schaffer Collateral-CA1 Field Recordings
Kainate-exposed (epileptic—αK, VK) and saline-injected
(non-epileptic—αC, VC) rats (n = 8 for each group) were
anesthetized with ketamine (65 mg/kg b.w., via i.p.) and killed
by decapitation. Brains were quickly removed and
parasagittal, 400-μm-thick slices were obtained as previously
described [35]. Field potential recordings were carried out
following a slice equilibration period in the interface-type re-
covering chamber maintained at room temperature.
Recording and bipolar stimulating electrodes were pre-
pared and filled with artificial cerebrospinal fluid as previous-
ly described [35]: the former electrode was placed in CA1
pyramidal cell layer and the latter in the stratum radiatum, at
approximately 500 μm of distance between them. Slices giv-
ing extracellular field excitatory postsynaptic potentials
(fEPSPs) of at least 1 mV in amplitude were considered for
recordings. To test basal synaptic transmission, input/output
curves were obtained applying to the slice square pulses of
current (300 μs in duration) with A385 stimulus isolator
(World Precision Instruments, USA): fEPSPs were elicited
in response to single electrical stimuli of increasingmagnitude
(from 0 to 160 pA, increments of 20 pA). Then, baseline
responses (60% of maximal fEPSP amplitude) were evoked
using low-frequency test pulses (at 30-s intervals) and
recorded over 30 min, a period sufficient to ensure stability.
Population spikes rising up from fEPSP were analyzed.
After a stable baseline was obtained, GABAA-receptor an-
tagonist bicuculline (BMI, 50 μM) and potassium channel
blocker 4-aminopyridine (4-AP, 50 μM) were added to bath
perfusion for 30 min, during which spontaneous drug-induced
extracellular field potential events (interictal) and fEPSPs
were recorded. The latency to the onset of epileptiform-like
activity was estimated.
Electrophysiological data analyses were performed offline
using a WinWCP software (Strathclyde electrophysiology
software, John Dempster, University of Strathclyde, UK).
Experiments and data analyses were performed in blind by
the operators.
GABAAR and AMPA Current Evaluation in Transfected
Xenopus Oocytes
Tissue Collection and Membrane Preparation Brain tissue
from αK and VK rats (n = 3 for each group) was snap frozen
immediately after collection in liquid nitrogen and stored at −
80 °C until further use. The preparation of rat membranes,
their injection in Xenopus laevis, GABA and AMPA current
recordings in oocytes expressing rat functional receptors was
carried out as previously described [36]. The use of female
Xenopus laevis frogs conformed to institutional policies and
guidelines of the Italian Ministry of Health (authorization no.
78/2015-PR).
Electrophysiology Twelve to 48 h after injection, membrane
currents were recorded from voltage clamped oocytes by
using two microelectrodes filled with 3 M KCl. Oocytes were
placed in a recording chamber (volume 0.1 ml) and perfused
continuously, 9–10 ml/min, with oocyte Ringer’s solution
(OR) at room temperature (20–22 °C).
GABA current rundown was defined as the percentage
decrease of the current peak amplitude after six 10-s applica-
tions of GABA 500 μM at 40-s intervals [36, 37].
Current–voltage (I–V) relationships were constructed hold-
ing the oocytes at − 60 mVand stepping the membrane poten-
tial for 2–4 min at the desired value before applying the neu-
rotransmitter. For these experiments, electrodes were filled
with K-Acetate (3 M—[38]) to reduce the leakage of a high
concentration of Cl− from electrodes into the oocytes.
However, the experiments gave the same results when KCl
filling solution was used (not shown). To determine the
EGABA, I–V relationships were fitted with a linear regression
curve-fitting (Sigmaplot 12) software.
Unless otherwise indicated, for all the experiments, GABA
500 μM was applied for 4 s.
In experiments involving AMPA currents, the oocytes were
pretreated for 20 s with cyclothiazide (CTZ, 20 μM), before
application of 10 s of AMPA, 20 μM [39]. Experiments
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involving 1 trimethylammonio-5-(1-adamantane-methyl-
ammoniopentane dibromide) (IEM 1460, a voltage-
dependent open channel blocker which preferentially blocks
GluA2-lacking AMPARs; [40]) were performed holding the
oocytes at − 80 mV; the current inhibition was calculated as
the ratio of the current blocked by IEM 1460 (I GluA2-
lacking) over the total IAMPA, expressed as a percent.
Chemicals were dissolved in sterile water (GABA, AMPA,
IEM 1460) or DMSO (CTZ) and stocked at − 20 °C until use.
For all the experiments, solutions were freshly prepared and
drugs and neurotransmitters were diluted to the desired con-
centration in OR. The composition of OR was the following:
82.5 mM NaCl; 2.5 mM KCl; 2.5 mM CaCl2; 1 mM MgCl2;
and 5 mM HEPES, adjusted to pH 7.4 with NaOH. The final
concentration of DMSO was always lower than 1:2000 after
dilution. All drugs were purchased from Tocris Bio-science
(Minneapolis, MN, USA) and OR salts from SIGMA (Saint
Louis, MO, USA).
Biochemical Analyses
Hippocampi from 16 rats (n = 4 for each group), killed by an
overdose of sodium tiopenthal via i.p., were quickly excised,
after transcardial perfusion with ice-cold physiological saline,
and stored at − 80 °C up to use. Hippocampi were then ho-
mogenized and lysed with 0.5 ml of ice-cold lysis buffer
[50 mM Tris–HCl, pH 7.8, 0.25 M sucrose, 1% (w/v) SDS,
1 μg/ml pepstatin, 10 μg/ml leupeptin, 2 mM sodium
orthovanadate, 10 mM NaF, 5 mM EDTA, 5 mM n-
ethylmaleimide, 40 μg/ml phenylmethylsulfonyl fluoride,
and 0.1% Nonidet-P40] and sonicated for 45 s at 50 W.
Oxidative stress evaluation and protein expression quantifica-
tion were performed.
Oxidative Stress Evaluation
Spectrophotometric Detection of Protein Carbonyls (PCO) To
determinate the level of oxidative stress, we used the measure-
ment of PCO in hippocampus samples using the molecule 2,4-
dinitrophenylhydrazine (DNPH) that is a specific probe able
to react with PCO leading to the formation of protein-
conjugated dinitrophenylhydrazones (DNP). These protein–
DNP adducts are characterized by a peak absorbance at
366 nm, which makes DNPH employment easy and useful
to perform a quantitative determination of PCO content by
spectrophotometer.
A step-by-step protocol to assay PCO was carried out in
accordance with [41]. Spectrophotometric measurements of
PCO content were performed at 366 nm, and results were
expressed as nanomoles of PCO per milligram of protein
(nmol/mg protein).
Electrophoresis and Western Blotting Analysis
Hippocampus samples were boiled for 4 min and then centri-
fuged for 10 min at 14,000×g to remove insoluble debris.
Supernatants were mixed 1:1 (vol/vol) with sample buffer
(0.5 M Tris–HCl, pH 6.8, 2% SDS, 10% glycerol, 4% of 2-
mercaptoethanol, and 0.05% bromophenol blue) and 30 μg of
sample proteins was loaded onto 10, 12, and 15% SDS–poly-
acrylamide slab gels and subjected to electrophoresis.
Prestained molecular mass markers (Bio-Rad, Milan, Italy)
were run on adjacent lanes. The gels were electroblotted and
stained with Coomassie brilliant blue R250. For immunoblot-
ting, the following antibodies were used: mouse monoclonal
antibodies against Claudin 5 (Thermo Fisher Scientific,
Waltham, Massachusetts, USA), GFAP (Sigma, Saint Louis,
MO, USA), inter leukin-1 β ( IL-1β ; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and interleukin-6
(IL-6; Santa Cruz Biotechnology, Santa Cruz, CA, USA); rab-
bit polyclonal anti-tumor necrosis factor-α (TNF-α; Sigma)
anti-IBA1 (Wako Life Sciences Inc., USA) and anti-actin
(Sigma, Saint Louis, MO, USA). Blots were incubated with
specific primary antibodies (1:1000) and subsequently with
the appropriate secondary antibodies conjugated with horse-
radish peroxidase (1:3000; Bio-Rad, Milan, Italy). Immune
complexes were visualized using an enhanced chemilumines-
cence Western blot analysis system (Amersham-Pharmacia,
Milan, Italy) followingmanufacturer’s specifications. Blot im-
ages were then digitized (Chemidoc, Bio-Rad) and areas of all
labeled bands were quantified using the computerized imaging
system software (QuantityOne; Bio-Rad). After antibody
probing, nitrocellulose membranes were stripped for 30 min
at 50 °C with stripping buffer (62.5 mM Tris–HCl, pH 6.7,
containing 10 mM β-mercaptoethanol and 2% SDS) and
reprobed with anti-actin (1:200). Immune complexes were vi-
sualized using an enhanced chemioluminescence. In each se-
ries, relative optical densities (arbitrary units) were normalized
for densitometric values obtained from actin-labeled bands.
MICRORNA Expression Analyses
Total RNA Extraction from Serum and Hippocampal
Homogenate
Peripheral blood samples were collected from anesthetized
rats (sodium tiopenthal, 45 mg/kg b.w. via i.p.; n = 3 for each
group) in appropriate tubes and, following 30 min resting at
RT, serum was obtained by centrifugation at 2500 rpm for
5 min at 4 °C. The synthetic Caenorhabditis elegans miR,
cel-miR-39, was spiked into rat serum before RNA extraction.
Hippocampi were then excised from the anesthetized rats
after killing and microRNAs were isolated from supernatant
of homogenates prepared as described above (see biochemical
analysis paragraph).
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After two subsequent spins, total RNAwas extracted from
100 μl of rat serum and homogenates using an RNA purifica-
tion kit (Norgen Biotek Corporation, Thorold, ON, Canada).
RNAwas stored at − 80 °C until use.
Quantitative Real-Time PCR (qRT-PCR) for Mature MicroRNA
Analysis
As previously performed [42, 43], microRNA (miRNA) ex-
pression was quantified using a real-time approach with the
TaqMan miRNA reverse transcription kit and a miRNA assay
(Applied Biosystems, Foster City, CA). The TaqMan
MicroRNA reverse transcription kit was used to reverse tran-
scribe the total RNA following manufacturer’s instructions.
Briefly, 5 μl of RT mix contained 1 μl of each miR-specific
stemloop primer (miR-126, miR-146a, and miR-124), 1.7 μl
of input RNA, 0.4 μl of 10 mM dNTPs, 0.3 μl of reverse
transcriptase, 0.5 μl of 10× buffer, 0.6 μ of RNAse inhibitor
diluted 1:10, and 0.5 μl of H2O. The mixture was incubated at
16 °C for 30 min, at 42 °C for 30 min, and at 85 °C for 5 min.
Afterwards, qRT-PCR was performed in 20 μl of PCR mix
containing 1 μl of 20× TaqMan MicroRNA assay (containing
PCR primers and probes; 5′-FAM), 10 μl of 2× TaqMan
Universal PCR Master Mix No UNG (Applied Biosystems),
1.33 μl of reverse-transcribed product, and 7.67 μl of
nuclease-free water. The reaction was first incubated at
95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s
and at 60 °C for 1 min. To obtain accurate and reproducible
results, the relative expression of circulating miRNAs was
quantified using synthetic C. elegans miRNA (cel-miR-39)
as the reference miRNA.
MicroRNA expression in homogenate was evaluated using
U6 as the reference. Each reaction was performed in duplicate.
The qRT-PCR was performed on an ABI PRISM 7500
Real-Time PCR System (Applied Biosystems). Data were an-
alyzed by a 7500 system software (1.1.4.0) with the automatic
comparative threshold (Ct) setting to adapt baseline. Detection
thresholds were set at 35 Ct. The relative amount of miR-
146a, miR-126, and miR-124 was calculated using the Ct
method:
Serum : ΔCt ¼ Ct miR−146a=miR−126=miR−124ð Þ−Ct cel−miR−39ð Þ; 2−ΔCt
Homogenate : ΔΔCt ¼ Ct miR−146a=miR−126=miR−124 treated sampleð Þ−Ct U6 treated sampleð Þ½ −
Ct miR−146a=miR−126=miR−124 control sampleð Þ−Ct U6 control sampleð Þ½ ; 2−ΔΔCt
Results are expressed in the figures as fold change related
to control sample (VC) and values less than 1 indicated down-
regulation, whereas values higher than 1 indicated up-
regulation.
MicroRNA Fluorescence In Situ Hybridization (FISH)
Twelve rats (n = 3 for each group) were deeply anesthe-
tized with sodium tiopenthal (via i.p.) and transcardially
perfused with physiological saline followed by 4% para-
formaldehyde (PFA) in phosphate buffered saline (PBS,
0.1 M; pH 7.4). Brains were removed, postfixed in 4%
PFA for 48 h, and then transferred in PBS. Brains were
embedded in paraffin and cut by a rotative microtome in
6-μm-thick coronal sections, which were processed for in
situ hybridization, using TSA™ Plus Fluorescence systems
through the miRCURY LNA™ ISH optimization Kit
(Exiqon, Euroclone, Italy); procedure for FISH detection
of microRNA was performed according to manufacturers’
instructions. Every step of the procedure, including tissue
sectioning, took place in a clean and nuclease-free environ-
ment. Briefly, PFA-fixed, paraffin-embedded sections were
mounted on slides, dewaxed, rehydrated with PBS, and
treated with Proteinase K solution at 37 °C for 20 min at
the concentration of 2 μg/ml in a Dako Hybridizer ma-
chine. Slides were then dehydrated in ethanol and air-
dried. The FISH probes (LNA™ microRNA probe,
LNA™ scrambled microRNA probe, and LNA™ U6
snRNA to set optimal hybridization conditions) were de-
natured at 90 °C for 4 min, before proceeding with the
hybridization of the probe with the specimen on the slides;
a coverslip was applied, sealed with rubber cement, and
sections were incubated at 55 °C for 1 h in a Dako
Hybridizer machine. Then, after coverslip removal, the
slides were placed in a glass jar containing SSC solutions,
put into a water bath set to the hybridization temperature to
ensure sufficient stringency. Following PBS washes, the
slides were placed in a humidifying chamber and incubated
with blocking solution (containing 2% sheep serum, 0.1%
Tween-20, 1% BSA in PBS) for 15 min at RT. Slides were
then incubated with anti-DIG-POD (1:400 in dilutant solu-
tion containing 1% sheep serum, 0.05% Tween-20, 1%
BSA in PBS) for 60 min at RT. Finally, TSA™ Plus
Fluorescein substrate (Perkin Elmer) substrate was applied
to the sections and incubated 2 × 5 min at RT. PBS buffer
washes were used to stop the reaction. The slides were
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covered directly with SlowFade Gold antifade reagent
(Life technologies–Thermo Fisher Scientific) and exam-
ined under a confocal microscope (Leica TCS-SL), with
suitable filter set.
To perform the densitometric analysis of FISH staining, six
slices for each experimental group were considered. Signal
intensity of miRNAs and U6 expressions were measured using
ImageJ (https://imagej.nih.gov/ij/) to calculate the product of
area and mean gray value (integrated density) as percentage
of modulation (miRNA percentage value versus U6).
Morphological Analyses
Twelve rats (n = 3 for each group) were deeply anesthetizedwith
sodium tiopenthal (via i.p.) and transcardially perfused with
physiological saline followed by 4% PFA in PBS. Brains were
removed, postfixed in 4% PFA for 48 h, and then transferred in
PBS. Vibratome was used to cut brains in serial sections (50 μm
thick), which were collected in PBS and mounted on slides.
FluoroJade staining was performed as previously described
[29]. Briefly, slideswere sequentially immersed in 100%ethanol
and then in 70% ethanol. After rinsing in distilled water, slides
were incubated in 0.06% KMnO4 solution, rinsed in distilled
water and transferred to a 0.001% solution of FluoroJade dis-
solved in 0.1% acetic acid. Slides were then rinsed in distilled
water, dried, immersed in xylene and coverslipped with
Entellan. FluoroJade-positive cells were observed by Axioskop
fluorescencemicroscope (Carl Zeiss, Germany) equippedwith a
filter suitable for visualizing fluorescein isothiocyanate; cells
with evident neuronal morphology were counted in at least six
sections for each animal taken along rostro-caudal extension of
CA1 hippocampal field. Eighty-five fields/animal (270 ×
250 μm each) were considered.
Statistical Analysis
Data were expressed as mean ± SEM. For multiple variable
comparison, results were analyzed using appropriate ANOVA
test (one-way or two-way) followed by Tukey’s post hoc test;
for single comparison, Student’s t test and χ2 test, unpaired t
test, or Wilcoxon signed-rank test, after normal distribution
testing (Shapiro-Wilk test) were appropriately used.
Significance threshold was established for p = 0.05.
Results
Electrophysiological Recordings
Population Spike Analysis
In order to assess differences in network excitability in hippo-
campus of non-epileptic and epileptic rats with and without α-
T post-ictal treatment, stimulations of Schaffer collaterals in
stratum radiatum of brain slices and recordings from CA1
pyramidal cell layer were performed.
In non-epileptic rats (αC and VC), extracellular stimula-
tion, during baseline recording, typically evoked a fEPSP
characterized by a single population spike (Fig. 1a); a second
population spike was rarely found in these groups of rats in
response to Schaffer collaterals stimulation (Fig. 1b).
Conversely, slices from kainate-treated rats showed a fEPSP,
which gave rise to one to three/four population spikes (Fig. 1a;
VK mean value 2.71 ± 0.24); notably, only slices from VK rats
exhibited up to four population spikes, while a great number of
αK slices evoked only one population spike, thus similarly to
non-epileptic rats (αK mean value 1.68 ± 0.17). Moreover, to
better investigate neuron excitability, the number of population
spikes was analyzed performing an input/output curve at in-
creasing stimulus magnitude; results showed that VK group
displayed a significantly higher number of population spikes
compared to αK, starting from 40 pA stimulus intensity
(Fig. 1b), indicating the occurrence of a greater network excit-
ability in absence of α-T post-ictal treatment.
Induced Epileptiform-Like Network Activity
Spontaneous appearance of epileptiform bursting events was
exclusively found in about 40% of recorded slices (n = 15) of
VK groups (χ2 test, p < 0.01), supporting the higher hyperex-
citability of the hippocampal network in this group of rats.
When BMI and 4-AP were co-applied in perfusion bath,
epileptic-like activity was induced in slices. The adopted
blocker concentrations were able to mainly evoke interictal
events, characterized by a duration of less than 400 ms, with
a positive peak and a negative one, clearly distinguishable
from baseline activity (Fig. 1c); ictal event, defined as consti-
tuted by at least three interictal events in rapid succession,
were rarely observed. As index of hyperexcitability, we eval-
uated the latency for the onset of the first interictal event.
Epileptic rats treated with α-T showed a latency for inducing
the first interictal event very similar to that of non-epileptic
rats with and without treatment, and significantly different
from that detected in non-treated epileptic rats (Fig. 1d), indi-
cating a less marked hippocampal excitability under α-T treat-
ment following SE.
GABAAR and AMPA Current Evaluation in Xenopus Oocytes
We tested the effect of α-T treatment on electrophysiological
properties of GABAA and AMPA receptors taking advantage
of the technique of membrane microtransplantation in
Xenopus oocytes.
First, we obtained a good expression of GABAA and AMPA
receptors using tissues from both treated and untreated rats
(mean IGABA—81.2 ± 26.5 nA VK, n = 14 vs. 101.8 ±
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31.4 nA αK, n = 13, p = 0.369; mean IAMPA—75 ± 33.5 nA
VK, n = 10 vs. 118.5 ± 43 nA αK, n = 14). This small variabil-
ity in the current amplitude is due to the difference of expression
between cells and donors (frogs) as previously reported [44,
45]. Furthermore, we focused on the evaluation of the electro-
physiological properties of the two receptors. As for GABAAR,
we found that a significant current rundownwas present in both
αK and VK hippocampal tissues (43 ± 7.5%, VK, n = 10 vs.
54.8 ± 6.9%, αK, n = 12, p = 0.259), suggesting that α-T does
not act on the degree of current desensitization as previously
reported for BDNF or fracktaline [37, 46].
Additionally, no differences of EGABA were observed be-
tween the two groups (VK = − 24.7 ± 1.2 mV; αK = − 22.6 ±
1.4 mV; p > 0.05 (n = 10)), thus indicating that a modification
of chloride homeostasis is not likely to be involved in the
effect evoked by the administration of α-T.
Furthermore, we analyzed IAMPA normalized to IGABA am-
plitude [47], but this parameter was similar in the two groups
(AMPA/GABA—VK = 304 ± 82%; αK = 239 ± 47%,
p > 0.05; n = 10).
To further characterize AMPA responses, we tested
IEM1460, a selective GluR2-lacking AMPA receptor blocker,
since GluR2 function is crucial in development and various
pathologies [40]. Our results showed that the percentage of
IEM1460 block was similar in the two groups (VK = 60.3 ±
16%; αK= 53 ± 14; p > 0.05, n = 8) indicating no difference
in the expression of GluR2 between two groups of rats.
Biochemical Results
Oxidative Stress Evaluation
The formation of PCO has been considered a marker of
oxidative stress in hippocampi derived from the different
experimental groups. In detail, the hippocampi of kainate-
Fig. 1 Effect ofα-tocopherol treatment on slice excitability in control and
kainate-induced rats. a Field excitatory postsynaptic potential (fEPSP)
recorded in CA1 pyramidal layer in treated kainate-exposed (αK) and
untreated kainate-exposed (VK) rats. The arrowhead indicates multiple
population spike recorded in VK rat slice. b fEPSP population spike
number recorded in the experimental groups: αK, treated kainate-
exposed; VK, untreated kainate-exposed; αC, treated non-epileptic;
VC, untreated non-epileptic, in response to Schaffer’s collaterals
stimulation (increasing intensities from 20 to 160 pA). Statistical
analyses performed by two-way ANOVA repeated measure, Tukey’s
post hoc: *p < 0.05; **p < 0.01. c Bath application of 50 μM BMI
together with 50 μM 4-AP leads to the appearance of spontaneous
interictal events: on the top, the enlarged view of a single event is
reported. d Latency of the first interictal event recorded in the
experimental groups. Statistical analyses performed by one-way
ANOVA, Tukey’s post hoc: *p < 0.05. All data are expressed as mean
± SEM
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induced epileptic rats (VK group) showed a significantly
larger amount of PCO as compared to α-T-treated epileptic
group (Fig. 2), which in turn resulted similar to that detect-
ed in non epileptic rats. Otherwise, no difference was
found in PCO content when α-T was administered under
control conditions. These findings indicate a reduction in
oxidative stress levels under α-T treatment conditions
15 days following SE.
Neuroinflammation Assessment
Fifteen days after SE, the expression levels of GFAP and IBA-
1 (used as a marker of reactive astrogliosis and of microglial
activation, respectively) were both significantly increased in
VK animals when compared to VC rats (Fig. 3); consistently,
the expression of pro-inflammatory cytokines IL-1β and
TNF-α was also up-regulated (Fig. 3), whereas IL-6 protein
levels appeared to not change. In αK rats, all the
neuroinflammatory markers were expressed to a significantly
lower extent than in VK (Fig. 3), except IL-6 which signifi-
cantly increased.
As a consequence of neuroinflammation, disruption of the
blood–brain barrier can occur, losing its capability to protect
brain environment. Claudin is a molecule forming tight junc-
tions, which limit the paracellular permeability. Thus, we eval-
uated the expression levels of this protein in hippocampi in
order to gain insight regarding the integrity of the blood–brain
barrier 15 days after SE. Densitometric analysis of immuno-
blots revealed a drastic decrease in claudin-5 protein levels in
kainate-exposed rats, which was recovered by α-T treatment
(Fig. 4).
MicroRNA Expression Modulation
Aberrantly expressed microRNAs that have already been
detected in hippocampus of epileptic patients (mTLE)
and TLE mice models (pilocarpine-induced SE) [48],
included miR-124, miR-126, and miR-146a. In particu-
lar, recent studies draw attention on the role of miR-
146a in the regulation of astroglia-mediated inflammato-
ry response [49], revealing its overexpression in
glioneuronal lesions from patients with medically intrac-
table epilepsy. In addition, miR-146a has been found to
modulate IL-6 expression by targeting IRAK-1 and
TRAF-6, key regulator proteins of TLR-4 signaling ac-
tivation [43].
Thus, to test for the differential expression of the
selected three miRNAs, such as miR-124, miR-126,
and miR-146a, among our experimental groups, we iso-
lated microRNAs from hippocampal homogenates. We
detected a significant up-regulation of miR-146a in hip-
pocampi of non-treated epileptic rats (VK) (Fig. 5a) as
compared to non-epileptic ones (VC), but this SE-
induced effect was completely prevented by α-T treat-
ment (αK) (Fig. 5a). On the contrary, a trend of de-
crease in miR-126 and miR-124 expression levels was
observed in epileptic hippocampi in comparison to VC;
after α-T treatment, the differences became statistically
significant. Interestingly, this effect was induced by α-T
also in absence of epileptic insult (αC).
Moreover, we measured circulating microRNAs in the se-
rum of the same rats belonging to the different experimental
groups. We uncovered changes for miR-146a and miR-124
that fit with those observed in the related hippocampi
(Fig. 5b); on the contrary, miR-126 serum levels were strongly
up-regulated following SE (VK), a phenomenon promptly
prevented by α-T treatment.
As far as miR-124 expression is concerned, both in
hippocampus and in serum, its expression was signifi-
cantly down-regulated by α-T. To further investigate its
low hippocampus expression, the fluorescence miR-124
in situ hybridization was performed in pyramidal neu-
rons of CA1 hippocampal fields. Even by using this
technique, we confirmed its down-regulation. MiR-124
signal was bright in pyramidal cells of CA1 hippocam-
pal field and restricted to cytoplasm (Fig. 6). The
brightness of the FISH signal was quenched in neuron
cytoplasm of α-T treated epileptic rats and was very
similar to that of the corresponding α-T non-epileptic
ones (Fig. 6).
All together, these results suggest an influence of α-T on
microRNA expression. In addition, circulating microRNAs
indicate that miR-126 and miR-146a may be biomarkers for
the epileptic disease and useful in the evaluation of the effec-
tiveness of treatment.
Fig. 2 Effect of α-tocopherol treatment on protein carbonyls (PCO)
formation used as marker of oxidative stress. PCO content (nmol/mg
protein) in the hippocampal homogenates obtained from rats of
different experimental groups: αK, treated kainate-exposed; VK,
untreated kainate-exposed; αC, treated non-epileptic; VC, untreated
non-epileptic. Histograms represent PCO content of three independent
measurements in each experimental group (means ± SEM). Statistical
analyses performed by one-way ANOVA and Tukey’s post hoc test:
**p < 0.01
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FluoroJade Analysis
Degenerating neurons were detected by FluoroJade staining.
Fifteen days following SE, epileptic hippocampi showed a
number of FluoroJade-positive cells, while no degenerating
neuron was found in saline-injected rats (αC; VC). VK rats
exhibited an overall greater number of degenerating neurons
across rostro-caudal extension of CA1 field (Fig. 7) than αK
hippocampi, which was highly significant at more caudal
brain levels (Fig. 7). This finding indicates a reduction in
neuronal degeneration due to α-T post-seizure treatment, thus
confirming and extending our previous finding [29].
Discussion
TLE, the most common form of partial epilepsy in humans, is
often preceded by a latent period, free from seizure, during
whichmaladaptive network reorganization occurs, thus induc-
ing the appearance of spontaneous recurrent seizures that
characterize the chronic stage [50]. Kainate status epilepticus
mimics the TLE disease [51], thus representing a validated
animal model to study the onset and development of chronic
epilepsy. The CA1 region of hippocampus following kainate-
induced SE is hyperexcitable, establishing a permissive factor
Fig. 3 Effect ofα-tocopherol treatment on neuroinflammatory markers in
control and kainate-induced epileptic rats. Western blot analysis of the
expression levels of neuroinflammatory markers in hippocampal
homogenates obtained from rats of the experimental groups: αK,
treated kainate-exposed; VK, untreated kainate-exposed; αC, treated
non-epileptic; VC, untreated non-epileptic. Per each marker protein:
representative immunoblots are displayed and anti-actin blots are shown
as loading control. Note that immunoblots are shown in the same
sequence as bars in the corresponding histograms. Histograms represent
densitometric analyses of blots from three independent experiments
(means ± SEM). Statistical analyses performed by one-way ANOVA
and Tukey’s post hoc test: *p < 0.05; **p < 0.01
Fig. 4 Effect of α-tocopherol treatment on blood–brain barrier in
control and kainate-induced epileptic rats. Western blot analysis of
the expression levels of claudin-5, used as marker of blood–brain
barrier integrity, in hippocampal homogenates obtained from rats of
the experimental groups: αK, treated kainate-exposed; VK,
untreated kainate-exposed; αC, treated non-epileptic; VC,
unt rea ted non-epi l ep t i c . Pe r each exper imenta l group :
representative immunoblots are displayed and anti-actin blots are
shown as loading control. Note that immunoblots are shown in the
same sequence as bars in the corresponding histograms. Histograms
represent densitometric analyses of blots from three independent
experiments (means ± SEM). Statistical analyses performed by one-
way ANOVA and Tukey’s post hoc test: **p < 0.01
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for the genesis and propagation of epileptic seizures. The pres-
ent study demonstrates that α-T treatment, started a few hours
after the overt SE, is able to strongly reduce CA1 hippocampal
neuron network excitability, decreasing the number of popu-
lation spikes evoked in slices by field recordings and reducing
the susceptibility to generate spontaneous and drug-triggered
epileptiform bursting events as observed 15 days after initial
insult; these electrophysiological parameters are considered
good markers in the evaluation of neuronal network excitabil-
ity during epileptogenesis [33, 52]. These findings would sup-
port the use of vitamin E in improving seizure control in pa-
tients with epilepsy [20], when added to the antiepileptic drugs
(AEDs). However, the mechanisms underlying the
antiepileptogenic effect of this natural compound have not
yet been fully investigated. Since a number of studies have
shown an increase in oxidative stress in epilepsy [53, 54],
vitamin E effectiveness in mitigating epilepsy severity in hu-
man patients and in animal models has been ascribed to its
well-known antioxidant property [19, 20]. By the way, our
findings regarding PCO determinations indicate the signifi-
cant reduction of oxidative stress level in hippocampus of α-
T-treated epileptic rats. Nevertheless, a series of studies re-
vealed that the forms of vitamin E, mainly α-T, are able to
function as signaling and gene regulation molecules indepen-
dently from their antioxidant action [55] and in the last few
years, several laboratories have described additional cellular
andmolecular properties for this vitamin, such as, reduction of
proliferation rate [56, 57], the enhancement of immune func-
tions, inflammatory pathway regulation, and neuroprotection
[29, 58–61].
α-Tocopherol Reduces Hippocampal
Neuroinflammation and Neurodegeneration
Neuronal cell loss, dendritic synapse elimination and synaptic
reorganization, imbalance in excitatory and inhibitory drive,
gliosis, and inflammatory pathway activation may contribute
to alter network excitability and synchronization during the
seizure-free latent period, accounting for epileptogenesis. In
this view, our previous study [29] has shown that 4 days of α-
T treatment after kainate-induced SE is able to (1) quench
neurodegenerative and neuroinflammatory processes trig-
gered by SE; (2) counteract glutamine synthase decline, re-
covering the glutamate–glutamine–GABA cycle pathway,
which has been found to be disrupted in the hippocampus of
patients affected by temporal lobe epilepsy (TLE) [62]; (3)
induce an increase in dendritic spine number and in
synaptophysin immunoreactivity, suggesting a role of α-T in
synaptogenesis promotion and/or synapse protection.
The present findings confirm and extend our previous ones,
showing that α-T treatment for 15 days following SE induc-
tion significantly reduce astrogliosis and microglial activation,
Fig. 5 Effect of α-tocopherol treatment on miR expression.
Quantification of miR-126, miR-146a, and miR-124 expression in
hippocampal homogenates (a), and quantification of serum miR-126,
miR-146a, and miR-124 expression (b) obtained from rats of the
different experimental groups: αK, treated kainate-exposed; VK,
untreated kainate-exposed; αC, treated non-epileptic; VC, untreated
non-epileptic. Statistical analyses performed by one-way ANOVA and
Tukey’s post hoc test: *p < 0.05; **p < 0.01. All data have been
normalized on VC miR expression level and expressed as mean ± SEM
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lowering the hippocampal expression of glial and microglial
markers and of pro-inflammatory cytokines IL-1β and
TNF-α; on the other hand, IL-6 protein levels are up-
regulated by α-T, whereas non-treated epileptic rats do not
show any difference with respect to both groups of non-
epileptic animals. This latter finding might be consistent with
the time-course of IL-6 induction, which has been found to
reach maximal levels within 24 h after SE and then decrease
after 3 days [63, 64]. IL-6 is a multifunctional cytokine with
pro- but also anti-inflammatory activities [65], and it has been
reported to contribute to neuroprotection after status epilepti-
cus [66]. In addition, the absence of IL-6 appears to be respon-
sible for a higher seizure susceptibi l i ty to some
chemoconvulsant agents [67]. Mechanisms underlying IL-6
neuroprotective effect have not been fully elucidated, but it
has been demonstrated to down-regulate the synthesis of pro-
inflammatory cytokines IL-1β and TNF-α [68, 69], thus lim-
iting neuroinflammation contribution to epileptogenesis. In
keeping with these observations, here we found a low protein
expression level of IL-1β and TNF-α in epileptic rats treated
with α-T as compared to the corresponding non-treated ones
that could in part come from their down-regulation induced by
IL-6. Interestingly, the small regulatory RNA molecule miR-
146a, an inflammation-associated microRNA up-regulated
during epileptogenesis and in the chronic epileptic phase in
rat hippocampus [70], has been recognized as an endogenous
Fig. 7 Effect of α-tocopherol treatment on neuronal degeneration.
Histogram reports the quantification of FluoroJade-positive cells in
CA1 hippocampal field in the different experimental groups. αK,
treated kainate-exposed; VK, untreated kainate-exposed. Plate A, −
3.3 mm; plate B, − 4.3 mm; and plate C, − 5.8 mm from bregma.
Statistical analyses performed by Student’s t test: **p < 0.01
Fig. 6 Effect of α-tocopherol treatment on miR-124 expression.
Representative confocal FISH images of fluorescent in situ
hybridization of miR-124 in CA1 pyramidal cells (scale bar 25 μm) (a).
Quantification of FISH intensity of miR-124 normalized to U6 snRNA in
CA1 pyramidal cells (b). αK, treated kainate-exposed; VK, untreated
kainate-exposed; αC, treated non-epileptic; VC, untreated non-epileptic.
All data are expressed as mean ± SEM. Statistical analyses performed by
one-way ANOVA and Tukey’s post hoc test: **p < 0.01
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regulator of cytokine signaling [71]. In this view, He et al. [72]
demonstrated that miR-146a inhibitor increased, while miR-
146a mimics decreased, the expression of IL-6 in LPS-
stimulated macrophages. In our experimental model, we
found that miR-146a expression was significantly enhanced
in VK rats in comparison to normal rats, and α-T treatment
was able to restrain miR-146a up-regulation in epileptic rats
15 days after SE induction. Considering that α-T was previ-
ously disclosed to down-regulate miRNA levels [24], we hy-
pothesize that it may be able to reducemiR-146a expression in
rat hippocampus during the latent period following SE induc-
tion and, as a consequence, to increase IL-6 release.Moreover,
it is worth mentioning that other mechanisms could be in-
volved in the neuroprotective effects of IL-6; indeed, it was
found to facilitate the concentration- and time-dependent up-
regulation of adenosine A1 receptor mRNA and signaling
[73] and adenosine has been shown to exert a powerful anti-
convulsant effect [74]. In addition, in vitro studies showed that
IL-6 is able to protect against glutamate- and NMDA-induced
excitotoxicity [75, 76].
Our present findings also corroborate the protection exerted
by α-T toward SE-induced neurodegeneration. Degenerating
neurons were scattered throughout the rostro-caudal CA1 ex-
tension, but they were mainly gathered at more caudal hippo-
campal levels, in which we detected a significantly lower
number of degenerating neurons in α-T-treated epileptic rats
in comparison to the corresponding non-treated ones. The
rostro-caudal gradient in vulnerability of CA1 to epileptic in-
jury could be consistent with the increasing degree of neuronal
excitability from dorsal to ventral hippocampus described by
several authors [77–81], and it is noteworthy that post-ictal α-
T administration is able to rescue CA1 neurons, showing a
corresponding region-specific pattern along the rostro-caudal
axis of hippocampus.
α-Tocopherol Promotes Blood–Brain Barrier (BBB)
Recovery
The BBB is a highly selective semipermeable membrane bar-
rier required to separate the circulating blood from brain ex-
tracellular fluid in the central nervous system (CNS); this abil-
ity is attributed to endothelial cells, which have continuous
tight junctions, lack fenestrations, and are characterized by
low pinocytotic activity. A compromised functioning of brain
endothelial cells results in serious consequences for BBB in-
tegrity [82] and therefore for brain homeostasis. BBB break-
down can be a direct consequence of seizure activity [83] due
to pro-inflammatory cytokine surge [27], inducing shifts in
vascular physiology, which is accompanied by entry into the
CNS of blood-borne entities ranging from small molecules to
whole cells [84, 85]. Tight junctions contain a complex of
transmembrane proteins, including claudin, the alteration of
which in the expression levels is indicative of a BBB damage.
We believe that this study shows, for the first time in this
experimental model, the ability of α-T to promote BBB re-
covery, probably by reducing neuroinflammation levels after
SE. This is a remarkable effect considering the crucial role
played by BBB in maintaining cerebral homeostasis and pro-
viding neuroprotection.
α-Tocopherol Affects microRNA Expression
in Hippocampus
Much evidence indicates that numerousmicroRNAs are dysreg-
ulated in epileptic brain of human and animal models [86]. In
keeping with these studies, here we found that miR-146a was
significantly up-regulated in hippocampus of non-treated epilep-
tic rats 15 days after SE induction, butα-T treatment was able to
prevent its overexpression. On the contrary, miR-126 and miR-
124 were significantly down-regulated in α-T-treated epileptic
hippocampi. It is remarkable that all the considered miRs
showed an alteration of their expression under α-T treatment
also in absence of the epileptic insult, thus indicating a possible
direct effect of the vitamin on miR expression. Consistently, a
redox-independent down-regulation of microRNA expression
by α-T has been previously reported [24].
The miR-146a appears to be a crucial mediator in the
neuroinflammatory response and it has been demonstrated [70]
that an up-regulation of miR-146a occurs in the latent period of
epileptic disease both in rat model and in human TLE, thus
suggesting a potential role played by these miRNAs in patho-
genesis of the disease. The expression of miR-146a is induced
by pro-inflammatory cytokines, mainly IL-1β [71, 87], and, in
turn, it has been suggested to act in a Bnegative regulatory loop^
[88] to fine-tune inflammatory response. In this context, wemay
hypothesize that α-T, since it decreases the expression levels of
IL-1β and TNF-α pro-inflammatory cytokines, is able to pre-
vent miR-146a up-regulation induced by SE, and that the re-
duced expression of miR-146a may increase, as discussed
above, IL-6 release, which contributes to further down-
regulate IL-1β and TNF-α protein levels.
miR-126 is highly expressed in endothelial cells, playing a
critical role in angiogenesis and blood vessel integrity [89,
90]; moreover, miR-126 has been demonstrated to regulate
the expression levels of endothelial adhesion molecules in
inflammation [91]. Recent findings uncovered a crucial role
for miRNAs, among which miR-126, in controlling the func-
tion of the barrier endothelium in the brain, which can be re-
duced by pro-inflammatory cytokines [27]. Here, we found that
miR-126 expression level tends to decrease in hippocampus
15 days following SE; this variation could be related to neuro-
inflammation occurrence which impairs BBB integrity as
shown by the dramatic loss of claudin-5 that we detected in
epileptic non-treated rats. Curiously, under α-T treatment con-
ditions, we observed a stronger decline of miR-126, but inde-
pendently from the induction of epileptic insult. This finding
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suggests that α-T per se may be a powerful regulator of miR-
126 expression in brain, thus affecting its downstream effectors,
including those related to cell growth and survival pathways
[92]. Indeed, miR-126 has been validated as a regulator of
SOX2 [93], which in the neural context is an important factor
in maintaining self-renewal and pluripotency of stem cells and
neural progenitors [94]. In addition, it is involved in EGFL7
pathway, which regulates Notch signaling in neural stem cells
altering their self-renewal and multipotency as well as their
differentiation potential [95]. Taking into account that we per-
formed miR-126 evaluation in the whole hippocampus, includ-
ing dentate gyrus in which neurogenesis occurs in normal and
pathological conditions such as epilepsy, and that previously we
found that α-T per se is able to modulate dentate gyrus
neurogenesis [96–98], our results could be affected by
neurogenetic events altered by epilepsy and treatment.
miR-124 is abundantly and specifically expressed in the
whole brain, and growing evidence is underpinning the link
between miR-124 dysregulation and central nervous system
(CNS) disorders [99]. Consistently, miR-124 has been dem-
onstrated to be useful as a diagnostic and prognostic indicator
of CNS pathologies, such as brain tumor and stroke [99].
Recently, miR-124 has been described to be involved also in
epilepsy in which it seems to play dual and opposing roles in
epileptogenesis; indeed, if on one hand, it has been shown to
attenuate epileptogenesis by preventing neuron-restrictive si-
lencer factor (NRSF) up-regulation involved in the develop-
ment of epilepsy, on the other hand, miR-124 exacerbates
inflammation promoting epilepsy [26]. In our experimental
conditions, we found that hippocampal miR-124 expression
was not significantly modified 15 days after kainic acid-
induced SE, even though it showed a trend toward down-
regulation. We further performed miR-124 FISH analysis,
and we found it to be expressed in cytoplasm of hippocampal
neurons, including pyramidal neurons of CA1 field. Both RT-
PCR quantitative analysis and FISH staining showed that un-
der α-T treatment conditions, miR-124 expression was signif-
icantly down-regulated 15 days following SE, but it was sim-
ilar to that of the corresponding non-epileptic rats, thus sug-
gesting a direct action of α-T per se also on miR-124 expres-
sion. However, considering the effect of α-T on neuron net-
work excitability, these findings could support a pro-
epileptogenic role played by miR-124 in epilepsy.
α-Tocopherol Affects MicroRNA Expression in Serum
The expression levels of microRNAs in blood have been recog-
nized to be clinically relevant as diagnostic/prognostic bio-
markers for a number of human diseases [100]. In keeping with
this evidence, we found that the modulation of serum miR-124
and miR-146a expressions in the different experimental rat
groups overlaps that observed in hippocampi from the same
animals, closely reproducing alterations induced by SE and α-
T treatment. In particular, miR-124 deserves attention since it is
specifically expressed in brain and it has been shown to be
useful as a diagnostic and prognostic tool in some brain disor-
ders. On the other hand, miR-126 evaluation in serum from
epileptic rats without α-T treatment unveiled an opposite trend
in comparison to that found in the corresponding hippocampi,
and it showed a significant up-regulation with respect to miR-
126 serum levels detected in all the other experimental groups.
Notably, this finding also demonstrates the reproducibility of the
α-T effect on miR-126 expression.
Thus, we believe that our findings allow us to propose that
the considered circulating microRNAs could serve as bio-
markers to follow up the effectiveness of the therapy for the
treatment of epilepsy.
α-Tocopherol Does Not Influence GABAAR and AMPA
Current
Imbalance in excitatory and inhibitory drive represents one of
the pathological mechanisms underlying the progression of
seizures, so that GABA, the most important inhibitory neuro-
transmitter in the CNS, and its receptors are considered the
main target of current and future antiepileptic drugs.
The occurrence of recurrent seizures is closely related to a
reduced efficacy of GABAergic inhibition [101]. Indeed, ep-
ileptic hippocampus has been found to show GABAA recep-
tors which become less responsive to repeated activation than
those from normal tissue both in humans and in animal model
of epilepsy [102–106]. This GABAA receptor desensitization
(known as GABAAR rundown) may be a crucial mechanism
in disrupting inhibitory function, contributing to excitation–
inhibition imbalance [25] and thus accountable for an increase
in excitability and for the occurrence of spontaneous seizures.
In this context, we found that α-T did not attenuate the SE-
induced degree of GABA current desensitization, displaying
both αK and VK hippocampal tissues a very similar marked
rundown during repetitive applications of GABA. Although
the molecular mechanisms underlying the increased GABAA-
receptor rundown in the epileptic tissue are still unknown, it
has been hypothesized that it could be ascribed to alterations
in GABAA receptor subunit composition [102] or to changes
in GABAAR phosphorylation/dephosphorylation [25]. Thus,
based on our results, we may suppose that α-T is unable to
affect GABAAergic receptor population structure nor their
function regulation. In addition, α-T post-ictal administration
does not seem to influence chloride homeostasis, suggesting
that chloride transport expression and/or activity are not al-
tered by the molecule administration. Finally, AMPA/GABA
current ratio was not different in the two groups, as well as
AMPA response and subunit composition, indicating no ef-
fects directly exerted byα-Talso on AMPA expression and/or
functioning.
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Conclusion
In the present work, we used a multidisciplinary approach for
the evaluation of the antiepileptogenic effect ofα-T isoform of
vitamin E and to investigate neurobiological correlates under-
lying this action. α-T treatment during the seizure-free latent
period after SE allows the reduction of maladaptive plasticity
processes, including neuroinflammation and neurodegenera-
tion, which promote the occurrence of spontaneous recurrent
seizures, inducing chronic epilepsy. Our main findings unveil
the actual and strong decrease in hippocampal network excit-
ability following SE under α-T treatment conditions and the
possible involvement of an α-T-mediated anti-inflammatory
mechanism in reducing epileptogenesis.
Furthermore, epileptic rats did not show any adverse reac-
tion linked to α-T treatment, such as significant weight loss,
bleeding, diarrhea, liver structure damage, etc., suggesting the
safety of α-T use as an antiepileptogenic agent. This is a very
relevant aspect because the absence of side effects associated
with any drug administration represents an essential positive
feature; indeed, adverse side effects of current AEDs are a
major impediment to optimal dosing for seizure control, main-
ly under drug-resistant epilepsy conditions. Hence, the search
for medications that treat epilepsy with minimal or no side
effects is gaining interest, and phytopharmaceuticals or alter-
native drugs or supplements are being considered as probable
candidates.
Interesting results have been obtained with the analysis of
miRNAs expression, but the α-T effect on microRNA modu-
lation observed in hippocampus will have to be deeply inves-
tigated. Future experiments will be needed to discover the
processes modulated by these miRNAs during our treatment
conditions. The in vivo miRNAs manipulation could be of
great support to further understand their direct involvement
in the α-T antiepileptogenic mechanism of action observed
in this study.
Finally, up-regulated circulating miR-126 and miR-146a
during epileptogenesis may be not only valuable diagnostic/
prognostic biomarkers but also useful biomarkers to evaluate
the clinical efficacy of specific treatments.
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